as 05-20-2024 4:00pm EST
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.
Founded: | 1942 | Country: | United States |
Employees: | N/A | City: | HAUPPAUGE |
Market Cap: | 42.6M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 8.0K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | 3.84% | Dividend Payout Frequency: | Semi-Annual |
EPS: | 0.60 | EPS Growth: | 15.38 |
52 Week Low/High: | $5.79 - $9.45 | Next Earning Date: | 05-10-2024 |
Revenue: | $11,569,774 | Revenue Growth: | 1.70% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
UG Breaking Stock News: Dive into UG Ticker-Specific Updates for Smart Investing
Associated Press Finance
10 days ago
GlobeNewswire
10 days ago
Simply Wall St.
a month ago
Simply Wall St.
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
4 months ago
Simply Wall St.
4 months ago
GuruFocus.com
4 months ago